David A. Eberhard

8.3k citations
54 papers · 5.6k · 1 hit paper · h-index 25

Impact in

Papers in

    • Molecular Biology Techniques and Applications 4
    • HER2/EGFR in Cancer Research 9
    • Colorectal Cancer Treatments and Studies 4

David A. Eberhard

54 papers receiving 5.4k citations

David A. Eberhard's Hit Papers

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib 2005 · 1.2k citations
1.2k0+7+14Years since publication4008001.2k

Peers

David A. Eberhard
Comparison fields: 5 of 122
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 1.9k
  • Cancer Research 825
  • Genetics 454
  • Molecular Biology 2.3k
Replace Karen Cichowski with:
Karen Cichowski United States
Francesca Carlomagno Italy
Francesco Hofmann Switzerland
Christophe Béroud France
Oriol Casanovas Spain
Raymond S. Yeung United States
Sandra Pastorino United States
Andrew B. Nixon United States
Arnab Chakravarti United States
Laura K. Shawver United States
David A. Eberhard relative to Karen Cichowski United States Karen Cichowski's profile →
Citations per field
00.5×1.6×
Karen Cichowski · 1×
Citations per year

Countries citing papers authored by David A. Eberhard

Since Specialization
Citations

This map shows the geographic impact of David A. Eberhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Eberhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Eberhard more than expected).

Fields of papers citing papers by David A. Eberhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Eberhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Eberhard. The network helps show where David A. Eberhard may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Eberhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Eberhard Line = papers co-authored together David A. Eberhard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
Hit paper breakdown →
20051238
2 2005483
3 2005440
4 2005391
5 1997283
6 2008249
7 1988226
8
Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.
2000210
9 1990208
10 2006202
11 1989197
12 2013178
13 1987122
14
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.
2002122
15 2012104
16
Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus.
1994103
17 200997
18 201394
19 199694
20 200182

About David A. Eberhard

David A. Eberhard is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Neurology, having authored 54 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), HER2/EGFR in Cancer Research (9 papers), Lung Cancer Treatments and Mutations (8 papers), Cellular transport and secretion (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Molecular Biology Techniques and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.9k citations), Cancer Research (825 citations), Genetics (454 citations) and Molecular Biology (2.3k citations). David A. Eberhard has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Ronald W. Holz, Bruce E. Johnson, Somasekar Seshagiri, Jeremy Stinson, Lukas C. Amler, Thomas Januario, Roy S. Herbst, Ladislau Steiner, Bernard F. Schneider and David H. Johnson. Their work appears in journals such as Journal of Clinical Oncology, Applied immunohistochemistry & molecular morphology, Neurology, Biochemical Journal and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact